Cargando…
Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial
PURPOSE: To quantify the effect on strength of semitendinosus (ST) graft harvest by comparing isokinetic and isometric muscle strength. METHODS: A cohort of 140 patients underwent anterior cruciate ligament (ACL) reconstruction (ACLR) and were randomized to ipsilateral or contralateral ST graft harv...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033693/ https://www.ncbi.nlm.nih.gov/pubmed/34368905 http://dx.doi.org/10.1007/s00167-021-06686-6 |
_version_ | 1784692952606441472 |
---|---|
author | von Essen, Christoffer McCallum, Sebastian Eriksson, Karl Barenius, Björn |
author_facet | von Essen, Christoffer McCallum, Sebastian Eriksson, Karl Barenius, Björn |
author_sort | von Essen, Christoffer |
collection | PubMed |
description | PURPOSE: To quantify the effect on strength of semitendinosus (ST) graft harvest by comparing isokinetic and isometric muscle strength. METHODS: A cohort of 140 patients underwent anterior cruciate ligament (ACL) reconstruction (ACLR) and were randomized to ipsilateral or contralateral ST graft harvest. Isokinetic and isometric muscle strength testing using a dynamometer were collected for the operated and non-operated leg. Patients were assessed pre-surgery and at 6, 12 and 24 months after reconstruction. RESULTS: ST graft harvest reduced isokinetic flexion muscle strength for 6 months. At 12 months follow up there was no significant difference between the two groups and they were all stronger than pre-injury. No other significant differences were found in any primary or secondary outcome measurements. CONCLUSION: Solitary ST graft harvest does not appear to result in a permanent reduced isometric or isokinetic quadriceps muscle strength on the side where the graft is harvested. A reduction in hamstring muscle strength of less than 10% can be seen at short-term follow-up with full recovery by 12 months. Most patients report little or no donor site pain. Given these findings, ST autograft is an alternative graft choice that could be used for various reconstructions in terms of donor site morbidity. LEVEL OF EVIDENCE: Level II. |
format | Online Article Text |
id | pubmed-9033693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-90336932022-05-06 Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial von Essen, Christoffer McCallum, Sebastian Eriksson, Karl Barenius, Björn Knee Surg Sports Traumatol Arthrosc Knee PURPOSE: To quantify the effect on strength of semitendinosus (ST) graft harvest by comparing isokinetic and isometric muscle strength. METHODS: A cohort of 140 patients underwent anterior cruciate ligament (ACL) reconstruction (ACLR) and were randomized to ipsilateral or contralateral ST graft harvest. Isokinetic and isometric muscle strength testing using a dynamometer were collected for the operated and non-operated leg. Patients were assessed pre-surgery and at 6, 12 and 24 months after reconstruction. RESULTS: ST graft harvest reduced isokinetic flexion muscle strength for 6 months. At 12 months follow up there was no significant difference between the two groups and they were all stronger than pre-injury. No other significant differences were found in any primary or secondary outcome measurements. CONCLUSION: Solitary ST graft harvest does not appear to result in a permanent reduced isometric or isokinetic quadriceps muscle strength on the side where the graft is harvested. A reduction in hamstring muscle strength of less than 10% can be seen at short-term follow-up with full recovery by 12 months. Most patients report little or no donor site pain. Given these findings, ST autograft is an alternative graft choice that could be used for various reconstructions in terms of donor site morbidity. LEVEL OF EVIDENCE: Level II. Springer Berlin Heidelberg 2021-08-08 2022 /pmc/articles/PMC9033693/ /pubmed/34368905 http://dx.doi.org/10.1007/s00167-021-06686-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Knee von Essen, Christoffer McCallum, Sebastian Eriksson, Karl Barenius, Björn Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial |
title | Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial |
title_full | Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial |
title_fullStr | Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial |
title_full_unstemmed | Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial |
title_short | Minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial |
title_sort | minimal graft site morbidity using autogenous semitendinosus graft from the uninjured leg: a randomised controlled trial |
topic | Knee |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033693/ https://www.ncbi.nlm.nih.gov/pubmed/34368905 http://dx.doi.org/10.1007/s00167-021-06686-6 |
work_keys_str_mv | AT vonessenchristoffer minimalgraftsitemorbidityusingautogenoussemitendinosusgraftfromtheuninjuredlegarandomisedcontrolledtrial AT mccallumsebastian minimalgraftsitemorbidityusingautogenoussemitendinosusgraftfromtheuninjuredlegarandomisedcontrolledtrial AT erikssonkarl minimalgraftsitemorbidityusingautogenoussemitendinosusgraftfromtheuninjuredlegarandomisedcontrolledtrial AT bareniusbjorn minimalgraftsitemorbidityusingautogenoussemitendinosusgraftfromtheuninjuredlegarandomisedcontrolledtrial |